Navigation Links
Study: MLB pitchers don't regain performance level after Tommy John surgery
Date:3/10/2014

DETROIT Major League Baseball players who undergo Tommy John surgery are less likely to regain the performance level they had before surgery, according to a Henry Ford Hospital study.

The study is the first to show a link between the surgery and declining pitching performance at the professional level. It also involved the largest cohort of professional pitchers to date to examine the issue.

Researchers analyzed pitching statistics of 168 MLB pitchers before and after surgery between 1982 and 2010 and found diminishing returns in three major pitching categories: Earned runs average (ERA), walks and hits per inning pitched (WHIP) and innings pitched (IP). The findings:

  • ERA increased 4.15 to 4.74.
  • WHIP increased 1.40 to 1.48.
  • IP declined 59 to 50.

"Tommy John surgery is an effective surgery and most pitchers get back to pitching after surgery. But it's not going to improve their level of performance," says Vasilios (Bill) Moutzouros, M.D., a Henry Ford orthopedic surgeon and the study's senior author.

"There's been a perception that the surgery will make you better. Our findings debunk that perception. Eighty to 90 percent of major league pitchers will get back to pitching at the major league level but they just won't be as effective as they were before injury."

The study is being presented at the annual meeting of the American Academy of Orthopedic Surgeons March 11-15 in New Orleans.

Tommy John surgery, named after the former Los Angeles Dodgers pitcher who underwent the pioneering surgery 40 years ago, has been since performed on legions of pitchers at the professional and collegiate levels. In medicine it is known as ulnar collateral ligament (UCL) reconstruction. During the two-hour outpatient procedure, the ulnar collateral ligament in the medial elbow is replaced with a tendon from the same arm or from the hamstring area.

Until Henry Ford's observational study, other research had shown that a high percentage of players returned to the same level of performance after UCL reconstruction, and the perception among players, coaches and parents was that UCL reconstruction would even lead to a higher level of performance. In the only other study involving just MLB pitchers (68 pitchers), 82 percent of them returned to the mound after surgery and had no significant decline in performance.

Henry Ford researchers sought to examine the effects of UCL reconstruction on pitching performance involving the largest cohort of MLB pitchers and identify risk factors associated with the pitching injury, says Robert Keller, M.D., a third-year Henry Ford orthopedic resident and study co-author whose father Phil was a teammate of Tommy John in the 1970s.

The cohort of 168 pitchers pitched in at least major league game after undergoing UCL reconstruction between 1982 and 2010. Data collected included the year of surgery, pitchers' age, years of MLB experience, height/weight, body mass index, pitching arm injured, pitching role, pitching statistics, and whether the pitcher returned to MLB pitching after surgery. This was then averaged for the three years of pitching before UCL reconstruction and for the three years after returning to play.

For comparison, researchers collected similar data of 178 MLB pitchers in a control group with no prior UCL reconstruction and age-matched them with a corresponding UCL reconstruction pitcher. Performance was determined using three years of statistics before their "index year" (their roster year of either 2004 or 2005) and three years after their "index year."

Drs. Moutzouros and Keller used paired analysis, generalized estimating equation model and other commonly used research tests to evaluate the data. Other highlights:

  • UCL pitchers were "statistically better" than the control group in ERA, WHIP, IP and win percentage in the three years and two years before surgery.
  • In the year before surgery, UCL pitchers' performance declined significantly.
  • After surgery, the control group was either superior in nearly every performance measure or no difference observed.
  • A predictor of surgery is MLB experience. Sixty percent of pitchers required UCL reconstruction within their first five years in the MLB.

While the cause of UCL injury is not fully known, orthopedic specialists theorize it's due to overuse and stress on the elbow, pitching velocity and joint motion, Dr. Keller says, adding that surgery isn't a panacea.

"We even have parents who come into our clinic asking if their children can have the surgery even before they injure anything because they think potentially it can make them better. What this study shows is it doesn't. Matter of fact, players get statistically worse after having this surgery."


'/>"/>

Contact: David Olejarz
David.Olejarz@hfhs.org
313-874-4094
Henry Ford Health System
Source:Eurekalert  

Related medicine news :

1. Study: Resilience in parents of children undergoing stem cell transplant
2. U of Maryland study: Partnership may help address cancer, health disparities
3. Study: Oropharyngeal cancer on the rise in young adults
4. Johns Hopkins study: Traumatic spinal cord injuries on the rise in US
5. Regenstrief, IU study: Half of hospitalized adults over 65 need surrogate decision-makers
6. Study: Possible new druggable target in Ewings Sarcoma
7. Study: Autophagy predicts which cancer cells live and die when faced with anti-cancer drugs
8. Study: Living Room offers alternative treatment for emotional distress
9. Study: Half of black males, 40 percent of white males arrested by age 23
10. New study: High mortality in Central Southern states most likely due to smoking
11. Embargoed study: New quality, payment initiative positively impacts pediatric care
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study: MLB pitchers don't regain performance level after Tommy John surgery
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... ... ... After raising nearly $30,000 on Kickstarter , about three-times its original ... discounted crowdfunding price on Indiegogo . , “Along with creating an anti-stress gadget ... a fidget toy to the market that was made of superior quality and wouldn’t ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Silver Birch ... community, which is located on more than four acres of land at 5620 Sohl ... , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each of ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon ... informational blog post on insurance options. If a Bay Area patient has to search ... time and money. Visiting an in-network provider for a second opinion can ensure a ...
(Date:5/26/2017)... ... ... FLINTHILLS FAMILY-Our Journey to the Cross”: the personal journey of Bob Massey and his faith ... published authors, Bob and Margaret Massey. Bob Massey is small in stature but big ... tough." His love for others is apparent in all of his life decisions. ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... -- Global Health Intelligence (GHI), the leading healthcare ... published its 2017 ranking of the Best-Equipped Hospitals in ... analysis from GHI,s hospitals database for Latin America , ... The GHI database covers 86% of the hospitals in ... points for each institution in key areas such as beds, ...
(Date:5/9/2017)... , May 9, 2017  Demonstrating its ... board of directors for the Pharmaceutical Research and ... for membership. Biopharmaceutical companies will now have to ... order to be eligible to join PhRMA. ... the board is sending a clear message that ...
(Date:5/6/2017)... Texas , May 5, 2017   Provista , ... with more than 200,000 customers, today announced Jim Cunniff ... a wealth of executive and business experience to Provista, including ... compounding pharmacy in California . He assumed ... "Jim is a great fit for Provista," says ...
Breaking Medicine Technology: